Thank you to our 2023 Exhibitors!

Alon Medical Technology, LLC proudly distributes Arthrex orthopedic and orthobiologic products to surgeons throughout Louisiana and Mississippi. We offer unparalleled customer service and educational opportunities via our state-of-the-art training labs, expansive video library, and customized educational events. With the most experienced, highly-trained sales team and technical consultants in the industry, Alon Medical Technology, LLC has emerged as the premier Arthrex distribution partner. With our real-time feedback mechanism, Alon customers have a direct line of communication in future Arthrex product development. Innovation and education are at the core of all we do. We are dedicated to Helping Our Surgeons Treat Their Patients Better.  For additional information please visit: www.alonmedical.com

DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve.

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. Our Orthopaedic Division offers a depth and breadth of allograft options unmatched in the industry.  Using minimal processing to maintain biomechanical integrity and biochemistry, we are known for our superior outcomes for every graft, every time.

Infinx Healthcare provides innovative and scalable payment lifecycle solutions for orthopedic, physical therapy, imaging, and various other healthcare practices. Combining an intelligent, cloud-based platform driven by artificial intelligence and automation, with our trained and certified prior authorization, coding and billing specialists, we help clients realize revenue, enabling them to shift focus from administrative details to billable patient care.

LAMMICO is a policyholder-owned insurance company that provides unparalleled service and comprehensive medical professional and general liability coverage at actuarially sound rates. With our personalized claim handling, aggressive legal defense and high quality risk management education, our policyholders can focus on what matters most: their patients. LAMMICO is the largest medical professional liability (MPL) insurance carrier domiciled in Louisiana and the only “A” (Excellent) rated Louisiana domiciled MPL insurance carrier insuring physicians, hospitals and facilities. LAMMICO is licensed to underwrite insurance in Louisiana, Arkansas, Mississippi and Tennessee. Coverage is also available in these and other states through the LAMMICO Risk Retention Group (RRG). The LAMMICO RRG supports out-of-state practice expansion of existing and new LAMMICO policyholders by providing a mechanism for coverage in states beyond those where LAMMICO is licensed. The LAMMICO RRG is licensed and domiciled in Washington, D.C. and registered to write business in Alabama, Arkansas, California, Georgia, Louisiana, Mississippi, Oklahoma, Tennessee and Texas.

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions as we partner with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedics products are distributed in more than 60 countries via the Company’s sales representatives and distributors. For more information, please visit www.Orthofix.com.

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy.  Founded in 2008, the company pioneered the surgical treatment of the SI joint with the iFuse Implant System. 

Current products, including applications in spinal deformity and SI joint trauma, have expanded the company’s scope within the sacropelvic space.  The iFuse Implant’s unique triangular geometry provides immediate stabilization, while the 3D printed porous surface facilitates osteointegration. With more than 45,000 procedures, 2,000+ treating surgeons and 80+ publications, iFuse is the leading choice in the surgical treatment of sacropelvic disorders.

Smith + Nephew has proudly supported healthcare professionals in their daily efforts to improve the lives of their patients for over 150 years.

Anika is a global joint preservation company committed to delivering meaningful advancements in early intervention orthopedic care, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and Arthrosurface joint technologies.

BONESUPPORT is the innovator of CERAMENT G with Gentamicin, the first and only FDA authorized combination antibiotic-eluting bone graft indicated for bone infection.  

CERAMENT G can be delivered in a single-stage procedure to simultaneously support bone remodeling and locally elute Gentamicin to protect bone healing.  It can help significantly reduce the recurrence of infection while improving patient outcomes and quality of life, and reducing healthcare costs.

CERAMENT G received Breakthrough Device Designation, an FDA categorization reserved for devices that treat serious and life-threatening conditions and which have demonstrated substantial improvement over other treatments and/or is the first of its kind.  CERAMENT G was also granted NTAP (New Technology Add-on Payment), which offers Medicare reimbursement to help healthcare organizations adopt new technologies.  For 2023, CERAMENT G has a maximum new technology add-on payment of $4,918.

Capitol Imaging Services is one of the largest independent radiology, outpatient imaging practices serving the Southeastern United States. Currently, Capitol Imaging Services manages centers from Louisiana to Texas and to Florida. We usually provide advanced imaging at a much lower cost to patients. Our mission we deliver to each and every patient is a warm welcome, pleasant experience and sincere thank you. 

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development and delivery of oncology and specialty medicines.  Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast, lung and gastric cancer, tenosynovial giant cell tumor and iron deficiency anemia. Visit us at www.daiichisankyo.us.

At Endo, our far-reaching vision is simple: to help everyone we serve live their best life. As a specialty pharmaceutical company, we work hard to make this vision more than just a worthy idea. Every day, we challenge ourselves with tough questions because we’re driven by a strong sense of purpose to find better ways to meet unique medical needs.

Our global, passionate team understands the importance that our work has on health and wellbeing. We’re dedicated to supporting one another as we connect with communities and foster partnerships that elevate quality of life and bring the best treatments forward.

Our uncompromising commitment results in the delivery of life-enhancing therapies. From intelligent product selection to commercialization, we strive to make a meaningful, tangible impact and help everyone live their best life.

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated

solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com/djo.

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, VuMedi, YouTube and Instagram.

Medacta is specialized in the design, production, and distribution of innovative orthopedic products and surgical techniques, supporting surgeons with comprehensive and tailored programs of medical education. Medacta is committed to improving the care and well-being of patients focusing on healthcare sustainability. Medacta’s innovation, forged by close collaboration with expert surgeons, began with minimally invasive techniques and has evolved into personalized solutions for every patient. 

MicroPort Orthopedics specializes in innovative total joint replacement solutions including the Evolution® Medial Pivot Knee System and Anterior PATH tissue-sparing approach supported by our Episode of Care philosophy.

At MicroPort Orthopedics, we are continually driven to leverage our extensive experience in orthopedics and 20 years of superior clinical results to improve patient outcomes and drive provider satisfaction across the globe.

The ModMed Orthopedics software suite is a cloud-based, all-in-one solution built to meet the needs of orthopedic practices. EMA®, our award-winning electronic health records (EHR) system, is designed to adapt to each surgeon’s style of practice, remembering preferences and automatically suggesting exam notes and billing codes. Available on desktop or touch-based devices, EMA® works seamlessly with our products and services including Practice Management, revenue cycle management, ModMed Telehealth, ModMed Pay, patient engagement tools and more. Our intuitive platform helps orthopedists and staff save precious time and focus more on improving and accelerating results for patients. Learn more about ModMed Orthopedics.

Next Science is a medical device company that pioneers innovative technologies to address one of the leading causes of antimicrobial resistance, bacterial biofilms.

At Sanara MedTech, our focus is on improving patient outcomes with evidence-based healing solutions.  We develop, market, and distribute wound and skincare products to physicians, hospitals, clinics and all post-acute care settings.

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. The company markets MACI® (autologous cultured chondrocytes on porcine collagen membrane), a third generation autologous cellularized scaffold product that is indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the adult knee, with or without bone involvement.

Workers Comp Options is a medical distributorship which helps create ancillary revenue for participating practices.

Xiros US focus products include Infinity-Lock™ Button System for ACJ reconstruction, Pitch Patch for Rotator Cuff repair, Infinity-Lock tapes for repair/reconstruction of tendons and ligaments, FlexPasser™ Tendon Retrieval Kit, for flexor tendon repair, and the Innovate Orthopaedics Quick Start Screw for repair fixation.  Visit www.xirosna.com for more information.